EBOS Group (EBOSF) Stock Price, News & Analysis

Company Overview

EBOS Group Limited (OTCMKTS: EBOSF) is a leading distributor of healthcare, medical, pharmaceutical and animal care products across the Asia-Pacific region. Headquartered in Auckland, New Zealand, the company sources, markets and supplies a broad range of consumables, devices and prescription medicines to hospitals, clinics, pharmacies, veterinary practices and livestock producers. EBOS Group’s operations span Australia, New Zealand and key Asian markets, where it combines local market expertise with international supply chains to deliver an extensive portfolio of products.

The company’s medical division offers a comprehensive suite of equipment and supplies, including surgical consumables, diagnostic devices, single-use products and specialised support services for acute and primary care settings. Through its pharmaceutical wholesale arm, EBOS Group distributes prescription and over-the-counter medications, vaccines and related healthcare goods to community pharmacies, hospitals and health practitioners.

In addition to human healthcare, EBOS Group maintains a substantial animal care business that serves companion animal veterinarians, livestock producers and ancillary agricultural markets. This segment supplies pharmaceuticals, vaccines, nutrition products and farm inputs designed to support animal health, welfare and productivity. The company’s multi-channel distribution network integrates traditional wholesale with direct-to-practice delivery and e-commerce capabilities.

Founded in 1922, EBOS Group has grown through strategic acquisitions and organic expansion to become one of Australasia’s largest healthcare distributors. The company is listed on the Australian Securities Exchange under the code EBO, with American depositary receipts trading on the OTC Markets under the symbol EBOSF. Its leadership team is headquartered in Auckland, where it oversees a workforce of several thousand employees dedicated to advancing healthcare and animal wellbeing across its core markets.

Key Stats

• Today's Range: $23.75 to $23.75
• 50-Day Range: $20.50 to $23.75
• 52-Week Range: $20.02 to $23.75
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EBOSF Stock Analysis - Frequently Asked Questions

How have EBOSF shares performed this year?

EBOS Group's stock was trading at $20.02 on January 1st, 2025. Since then, EBOSF shares have increased by 18.6% and is now trading at $23.75.

How do I buy shares of EBOS Group?

Shares of EBOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Distribution
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EBOSF
• CIK: 1533082
• Web: www.ebosgroup.com
• Phone: 61-3-9918-5555
• Fax: N/A
• Employees: 5,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A